Astrazeneca's US Arm COVID-19 Vaccine Trial Will Not Resume Until Midweek As FDA Probes Serious Spinal Cord Side Effect AstraZeneca will face a probe from the US FDA for its vaccine trials—a serious side effect pose threats to the shot. Is this a failed vaccine? by Isaiah Alonzo